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The latency-related transcript (LRT) of bovine herpesvirus 1 (BHV-1) is the only abundant viral RNA
detected during latency. A previous study (A. Hossain, L. M. Schang, and C. Jones, J. Virol. 69:5345–5352,
1995) concluded that splicing of polyadenylated [poly(A)1] and splicing of nonpolyadenylated [poly(A)2] LRT
are different. In this study, splice junction sites of LRT were identified. In trigeminal ganglia of acutely infected
calves (1, 7, or 15 days postinfection [p.i.]) or in latently infected calves (60 days p.i.), alternative splicing of
poly(A)1 LRT occurred. Productive viral gene expression in trigeminal ganglia is readily detected from 2 to 7
days p.i. but not at 15 days p.i. (L. M. Schang and C. Jones, J. Virol. 71:6786–6795, 1997), suggesting that
certain aspects of a lytic infection occur in neurons and that these factors influence LRT splicing. Splicing of
poly(A)2 LRT was also detected in transfected COS-7 cells or infected MDBK cells. DNA sequence analysis of
spliced LRT cDNAs, poly(A)1 or poly(A)2, revealed nonconsensus splice signals at exon/intron and intron/
exon boundaries. The GC-AG splicing signal utilized by the herpes simplex virus type 1 latency-associated
transcript in latently infected mice is also used by LRT in latently infected calves. Taken together, these results
led us to hypothesize that (i) poly(A)1 LRT is spliced in trigeminal ganglia by neuron-specific factors, (ii) viral
or virus-induced factors participate in splicing, and (iii) alternative splicing of LRT may result in protein
isoforms which have novel biological properties.
All members of the alphaherpesvirus subfamily establish and
maintain a latent infection in the peripheral nervous system of
their natural hosts. Bovine herpesvirus 1 (BHV-1), a member
of the alphaherpesvirus subfamily, is an important pathogen of
cattle and establishes latent infection in sensory ganglia of
infected cattle (reviewed in references 57 and 58). Since neu-
rons are terminally differentiated cells, it may not be necessary
for the virus to replicate in these cells to maintain latency.
Viral gene expression in latently infected neurons is restricted
to the latency-related transcript (LRT). By using in situ hy-
bridization, LRT was detected in trigeminal ganglia (TG) of
BHV-1-infected rabbits (55, 56) or cattle (41). These studies
mapped the approximate 59 and 39 ends of LRT and estimated
its length to be 1.15 kb. LRT is also expressed during the late
stages of productively infected bovine cells (56). A 41-kDa
protein is encoded by the LR (latency-related) gene in tran-
siently transfected cells or infected bovine cells (35). LR gene
products inhibit entry of cells into S phase, suggesting that the
LR gene regulates some aspect of latency (65).
The latency-associated transcript (LAT) of herpes simplex
virus type 1 (HSV-1) has been the subject of intense scrutiny
(reviewed in references 4, 9 24, 34, and 80). It is not known if
HSV-1 LAT encodes a protein even though LAT is associated
with polysomes (28). LAT is a stable 2.0-kb intron (22, 40, 59,
83), and the 1.5- or 1.45-kb transcript is derived from the 2.0-kb
LAT by further splicing (71). The splicing event that generates
the 1.5-kb LAT utilizes a novel splice donor that is GC instead
of GT (71, 74), and this splicing event requires neuron-specific
splicing factors (44). Polyadenylation of the spliced 1.5-kb LAT
is controversial (18, 50, 52, 70, 79). Disruption of splice donor
or acceptor sites prevents synthesis of the 2-kb LAT in pro-
ductively infected nonneuronal cells but not in latently infected
neurons (3).
Although cis-acting sequences that regulate neuron-specific
transcription of the BHV-1 LR gene have been studied (10, 11,
17, 37), processing of LRT has not been well characterized. A
previous study concluded that LRT is spliced, but splice junc-
tions were not identified (35). In this study, LRT splicing pat-
terns in TG of infected calves were compared to those of
productively infected bovine cells or COS-7 cells transfected
with a plasmid that expresses LR gene products. We have
identified three alternatively spliced poly(A)1 LRT isoforms at
7, 15, or 60 days postinfection (p.i.). A spliced poly(A)2 LRT
was detected at 1 day p.i., suggesting LRT is expressed early in
TG. LRT was spliced in the poly(A)2 RNA fraction after
bovine cells were infected or after COS-7 cells were trans-
fected with a plasmid containing the LR gene. It is hypothe-
sized that poly(A)1 LRT is alternatively spliced in TG and that
these spliced variants have the potential to encode novel pro-
teins.
MATERIALS AND METHODS
Virus, plasmids, and cells. MDBK (Madin-Darby bovine kidney) cells or
COS-7 cells (American Type Culture Collection, Rockville, Md.) were grown in
Earle’s modified Eagle’s medium supplemented with 10% fetal calf serum. The
Cooper strain of BHV-1 was obtained from the National Veterinary Services
Laboratory, Animal and Plant Health Inspection Services (Ames, Iowa). MDBK
cells were infected with 5 PFU of BHV-1 per cell, and RNA was extracted 24 h
p.i.
Plasmid pcDNA1/LRT was constructed by inserting a 2-kb HindIII-SalI frag-
ment which contains the LR gene (35) (Fig. 1) into the mammalian expression
vector pcDNA1/Amp (Invitrogen). A SalI site was inserted into the unique XbaI
site of pcDNA1/Amp prior to insertion of the LR gene. COS-7 cells were
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transfected with pcDNA1/LRT by calcium phosphate precipitation (19), and
total RNA was prepared 48 h after transfection.
Infection of cattle and preparation of tissue samples. BHV-1-free calves were
divided into six groups of two each and then infected with 108.8 50% tissue
culture infective doses intranasally and intraocularly as described previously (66).
Two animals were used as controls. TG were collected 1, 2, 4, 7, 15, or 60 days
p.i. (two calves per time point) or from two uninfected calves. TG were frozen in
an ethanol-dry ice bath and stored at 2120°C (66). Some of the RNA samples
from the cattle described by Schang and Jones (66) were used for these studies.
Preparation of RNA. Total RNA was extracted from TG as described previ-
ously (35). Total RNA from infected or transfected cells was extracted by using
the RNAgents Total RNA Isolation system (catalog no. Z5110; Promega) ac-
cording to the manufacturer’s instructions. RNA concentrations were measured
in a spectrophotometer at 260 nm.
Preparation of poly(A)1 and poly(A)2 LRT RNA by oligo(dT) chromatogra-
phy. Poly(A)1 RNA was prepared by using an mRNA purification kit (catalog
no. 27-9258; Pharmacia) according to manufacturer’s instructions. Total RNA
was passed through an oligo(dT)-cellulose column twice, and the column was
washed with a buffer supplied in the kit. Bound RNA was recovered by incubat-
ing the column with 250 ml of elution buffer at 65°C, and RNA was subsequently
precipitated with ethanol. RNA in the flowthrough fraction of the oligo(dT)
column [designated poly(A2)] was recovered and precipitated with ethanol.
Primers for RT-PCR. Figure 1 shows the design of primers used for reverse
transcriptase (RT)-mediated PCR (RT-PCR) and location of the hybridization
probe. LRT was detected by using primers P1 (same sense as LRT 59-AGGCT
GGGGGTCGCAAATACACGGC-39) and P2 (antisense to LRT 59-GGCCCG
CCGGAGAAGAAGGACAGAGT-39), which amplify a 757-bp fragment. With
primers P3 (same sense as LRT 59-CCCCAGGAGGCTTTCTCGCACC-39) and
primer P4 (antisense to LRT 59-CACAGTGATAGACCTGACGGCGAACG-
39), spliced LRT was amplified. The probe used for detection of LRT cDNA was
from nucleotides (nt) 1092 to 1117 (59-GCGCACCGAAATGGAAGTGGCCG
CC-39). The numbering system for the LR gene was described previously (41)
and is based on the Cooper strain of BHV-1. The 39 termini of primers P1, P2,
P3, and P4 correspond to positions 872, 1629, 1068, and 1523, respectively. The
primers were designed based on the following criteria: (i) the oligonucleotides
are located adjacent to an AT-rich region, (ii) the oligonucleotides have a GC
content greater than 50%, (iii) there is no significant similarity to other viral
genes, and (iv) PCR product size is more than 300 bp.
RT-PCR and sequence analysis of cDNAs. The method for RT-PCR was
described previously (14). Prior to cDNA synthesis, RNA was treated with 1 U
of DNase I (GIBCO-BRL) to eliminate contaminating DNA (20). Five hundred
nanograms of DNase I-treated poly(A)1 or 3 mg of poly(A)2 RNA was dena-
tured at 65°C for 7.5 min, incubated at room temperature with 1 mg of oligo(dT)
or random primers (Invitrogen) for 15 min, and then incubated on ice. This
mixture was incubated with 200 U of Moloney murine leukemia virus RT
(GIBCO-BRL) in the presence of 20 U of RNase inhibitor (Promega) according
to the manufacturer’s instructions for synthesis of cDNA. RT was inactivated by
heating at 95°C for 5 min. Amplification of cDNA was conducted with 2.5 U of
Taq DNA polymerase and 100 mM deoxynucleoside triphosphates in a 50-ml
reaction. Forty cycles of amplification were carried out with primers P1 and P2
(200 ng of each) in the presence of 10% glycerol to improve denaturation of
GC-rich DNA and to enhance the extension through secondary structures (68)
on a DNA thermal cycler (Hybaid). The following conditions were used for
amplification: 1 min at 94°C (denaturation), 2 min at 55°C (annealing), 2 min at
72°C (polymerization), and 7 min at 72°C to complete the extension. The PCR
products were then reamplified with primers P3 and P4 (200 ng of each) under
the same conditions. To avoid contamination, PCR was performed in a separate
room, gloves were changed frequently, all reagents were used exclusively for
these studies, and numerous other precautions were taken to avoid contamina-
tion (32). Amplified products were purified either by polyacrylamide gel elec-
trophoresis or by selective precipitation (62). Briefly, 0.1 volume of 103 STE (1
M NaCl, 200 mM Tris-HCl [pH 7.5], 100 mM EDTA) was added to PCR
products, followed by addition of equal amounts of 4 M ammonium acetate, and
precipitated with 2.5 volumes of ethanol at room temperature. Purified PCR
products were cloned into pCR-Script vector (Stratagene) according to the
manufacturer’s instructions. Both strands of the inserts were sequenced by the
dideoxynucleotide chain termination method using the Fidelity DNA sequencing
system (catalog no. 57600; Oncor), which is designed for sequencing GC-rich
DNA. As a positive control, BHV-1 DNA was used. Negative controls included
RNA from TG of uninfected calves, mock-infected MDBK cells, or mock-
transfected COS-7 cells.
Southern blot analysis. PCR products were separated on 2% agarose gels and
transferred onto Hybond N1 membrane (Amersham) by capillary transfer ac-
cording to the protocol of the manufacturer. Hybridization was done according
to the manufacturer’s instructions. The probe was prepared by end labeling with
T4 polynucleotide kinase (New England Biolabs) and [g-32P]ATP (Amersham).
RESULTS
Amplification of LRT splice junction sites by RT-PCR. A
previous study (35) demonstrated that splicing of LRT oc-
curred, but splice junction sites were not identified. To further
study splicing of LRT, RT-PCR was conducted because this
approach has been used successfully to identify alternative
splicing of other primary transcripts (15, 23, 54). To this end,
total RNA from TG of infected calves was used. Poly(A)1
RNA was purified by oligo(dT) chromatography. No attempts
were made to prove how efficient the purification procedure
was because unnecessary manipulation of TG RNA increases
the probability of degradation. To avoid amplification of con-
taminating viral DNA, total RNA was treated with DNase I.
Single-stranded cDNA was synthesized by using an oligo(dT)
primer, RT, and conditions which allow for optimal amplifica-
tion of LRT. The resulting cDNA was then amplified in a
nested PCR using the primers shown in Fig. 1. The rationale
for using nested PCR is that (i) primers P1 and P2 are adjacent
to the transcription start sites (11) and the poly(A) signals (41),
(ii) primers P3 and P4 flank the region which was spliced (35),
and (iii) this strategy enables detection of small amounts of
LRT. Although these primers will amplify the IE2.9/E2.6
mRNA, this region of the RNA is not spliced (82), and thus the
amplified product migrates with the same mobility as genomic
DNA (data not shown).
Poly(A)1 LRT was detected in bovine TG at 7, 15, or 60
days p.i. (Fig. 2A). A previous study demonstrated that infec-
tious virus was detected in ocular swabs at 2, 4, or 7 days p.i.
but not 15 or 60 days p.i. (66). Alternative splicing apparently
occurred in TG during acute infection because amplified prod-
ucts detected at 7 or 15 days p.i. were smaller than amplified
LR DNA or LRT cDNA at 60 days p.i. Amplified products
were not detected when RT was excluded from the cDNA
synthesis (Fig. 2B) or when RNA was prepared from TG of an
uninfected calf (Fig. 2A, lane U).
The flowthrough from the oligo(dT) column [poly(A)2
RNA] was subjected to cDNA synthesis using random primers
and nested PCR to detect LRT. A 455-bp PCR product was
detected by Southern blot analysis using the LRT-specific
probe described in Fig. 1 (Fig. 3A, lanes 2, 7, and 15). Ampli-
FIG. 1. Schematic of the LR promoter, locations of 59 termini of LR tran-
scripts, and partial restriction enzyme map of the LR gene. The 59 ends of LRT
were mapped by RACE (rapid amplification of cDNA ends) PCR or primer
extension (11, 35). DNA sequences within the LR promoter which are bound by
neuron-specific proteins (NSB) were identified by electrophoretic mobility shift
assays and exonuclease III footprinting (17). DNA sequences within the LR
promoter which cis activate a minimal tk promoter in neuronal cells are desig-
nated as a neuron-specific transcriptional activator (NSTA) (10). Splicing of LR
RNA occurs in LRT; this is designated by the dashed lines (35). The transcripts
(IE2.9/E2.6) antisense to LRT are indicated by a solid black line, and the circle
at the 39 end of the transcript is the position of the stop codons for the protein
encoded by IE2.9/E2.6. The primers P1, P2, P3, and P4 used for amplification of
LRT are indicated by small black rectangles. The number below each primer
indicates the position of the 59 terminus. The predicted sizes of the PCR products
that can be amplified by these primers are also indicated. The small hatched
rectangle indicates the probe used in Southern blot analysis to detect the PCR
product. Except for the boxes depicting P1, P2, P3, P4, and the probe, the line
map is drawn to scale. Plasmid pcDNA1/LRT contains the 2-kb HindIII-SalI
fragment cloned into pcDNA1/Amp as described in Materials and Methods.
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fied products were not detected when RT was omitted from the
cDNA synthesis reaction (Fig. 3B). Poly(A)2 LRT was also
detected at 1 day p.i. (Fig. 3A, lane 1), and the PCR product
appeared to be slightly smaller than genomic viral DNA. Fur-
thermore, poly(A)2 LRT from latently infected animals (60
days p.i.) migrated as a 455-bp amplified product (Fig. 3C, lane
1), and the specificity of the amplified product was confirmed
by Southern blot hybridization (data not shown). As expected,
amplified products were not observed when RT was left out of
the cDNA synthesis reaction (Fig. 3C, lane 2). RNA from TG
of a second set of infected calves yielded similar bands (data
not shown). In summary, these results demonstrated that (i)
alternative splicing of poly(A)1 LRT occurred in TG during
acute infection, (ii) splicing of poly(A)2 LRT apparently oc-
curred at 1 day p.i., and (iii) splicing of poly(A)2 LRT in TG
at 2, 7, 15, or 60 days p.i. was not readily detected.
Analysis of LRT synthesized in transfected or infected cells.
A protein product was identified in COS-7 cells transfected
with the LR gene or after MDBK cells were infected (35, 65).
In this study, splicing of LRT was investigated after COS-7
cells were transfected with a plasmid expressing LR gene prod-
ucts or after MDBK cells were infected with BHV-1. Total
RNA was extracted 48 h after transfection or 24 h after infec-
tion. Following DNase I treatment, poly(A)1 RNA was used as
a template to synthesize single-stranded cDNA with an oli-
go(dT) primer, and LRT cDNA was amplified. Although
poly(A)1 LRT was detected in transfected or infected cells,
spliced poly(A)1 LRT was not detected, as judged by the size
of the PCR product (Fig. 4A, lane 2 or 5). A previous study
detected small amounts of spliced poly(A)1 LRT in infected
MDBK cells (35). Although the results in Fig. 4A appear to be
at odds with that conclusion, the RNA used for this study was
purified by oligo(dT) chromatography. Thus, we hypothesize
that either the spliced poly(A)1 LRT was degraded during
purification, the poly(A) tail was too short to be stably bound
on an oligo(dT) column, or the use of a strand-specific primer
in the previous study (35) allowed detection of small amounts
of spliced poly(A)1 LRT in infected MDBK cells.
When cDNA synthesis of poly(A)2 RNA was primed with a
random primer and LRT cDNA was amplified by nested PCR,
bands smaller than amplified BHV-1 DNA (455 bp) were de-
tected (Fig. 4B, lanes 2 and 5). poly(A)2 RNA which was
prepared from productively infected cells yielded amplified
products migrating as 280-, 240-, or 200-bp fragments (Fig. 4B,
lane 5). In contrast, poly(A)2 RNA in transiently transfected
COS-7 cells contained bands migrating as 455-, 300-, or 200-bp
fragments (Fig. 4B, lane 2). All of the amplified products
hybridized to the LR-specific probe described in Fig. 1 (data
not shown). No PCR products were observed when RT was left
out of the cDNA synthesis reaction (Fig. 4A and B, lanes 3 and
6). Unspliced poly(A)2 LRT was also detected in transfected
cells because a 455-bp band was amplified (Fig. 4B, lane 2).
Plasmid pcDNA1/LRT does not contain the IE2.9/E2.6 gene,
demonstrating that LRT can be spliced in the absence of any
other known viral gene and a subset of LRT was not spliced. In
summary, these results indicated that poly(A)2 LRT was
FIG. 2. Detection of splicing in poly(A)1 LR RNA in TG of infected cattle.
The cDNA reaction containing RT was subsequently amplified by using the
LRT-specific primers in the nested PCR (A). Lane V, BHV-1 genomic DNA
used as an unspliced target; lane U, RNA from TG of an uninfected calf.
Numbers above the lanes indicate the days p.i. at which RNA was prepared from
TG. f174 DNA which was digested with HaeIII was used as a molecular weight
marker, and the positions of the bands are listed as base pairs. RNA samples
were incubated in the standard RT reaction, but RT was omitted and then the
nested PCR was performed (B). The lanes are labeled as in panel A. PCR
products were detected by Southern blot analysis as described in Materials and
Methods.
FIG. 3. Analysis of poly(A)2 LR RNA. (A) Southern blot analysis of PCR-amplified products derived from the reaction performed with RT. BHV-1 genomic DNA
was used as a positive control (lane V). Lane M, RNA from an uninfected calf. Numbers above the lanes indicate RNA prepared from TG which were obtained at
different days p.i. The arrow indicates the position of LRT. (B) Southern blot analysis of PCR products derived from the reaction performed without RT. Water was
used as a negative control (lane V). The remainder of the lanes are labeled as described for panel A. f174 DNA digested with HaeIII was used as a marker, and the
positions of the bands are designated in base pairs. (C) Amplification of poly(A)2 LR RNA from latently infected calves (60 days p.i.). Lane M, f174 DNA digested
with HaeIII; lane U, RNA prepared from TG of an uninfected calf; lane 1, reaction with RT and LRT cDNA subsequently amplified; lane 2, reaction without RT
followed by PCR to amplify LRT cDNA.
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spliced in MDBK cells after infection or when COS-7 cells
were transfected with pcDNA1/LRT.
Sequencing of cloned fragments spanning LRT splice sites.
Although it was possible to sequence the PCR products di-
rectly, they were cloned into the pCR-Script vector prior to
DNA sequencing. This approach was used in an attempt to
identify minor splice site variants and to enhance selection of
full-length products. Purified PCR products shown in Fig. 2A,
3A and C, and 4B were cloned into pCR-Script vector. A
fragment migrating as a 200-bp fragment was the only band
less than 455 bp which was able to be cloned from transfected
COS-7 cells or infected MDBK cells (Fig. 4B, lanes 2 and 5).
Prior to DNA sequencing, plasmids were analyzed by restric-
tion enzyme digestion to verify that the inserts were similar in
size to the amplified products. Less than 2% of the plasmids
had different-size inserts, suggesting that most of the PCR
products were not deleted during cloning. DNA sequence of
these variants did not match the published LRT gene se-
quence, indicating they were rearranged during cloning or
were not bona fide LRT cDNAs. In contrast, fragments mi-
grating at the expected position of the amplified product
yielded DNA sequence which matched the LR gene sequence
with an interruption in the middle. The 455-bp PCR product
matched the known sequence of the LR gene but did not
contain an interruption and thus was not spliced. Figure 5
shows representative examples of the DNA sequence spanning
splice junction sites at 1, 7, or 15 days p.i. from TG. At least 10
independent clones were sequenced for each time point, and
they yielded the same sequence (locations of splice sites are
summarized in Fig. 6).
Regardless of whether LRT was poly(A)1 or poly(A)2,
splice sites did not match consensus 59 or 39 splice sites (Table
1). The 59 splice sites of poly(A)1 LRT at 60 days p.i. were GC,
and they match the 59 splice site of HSV-1 LAT (71, 74), duck
a-globin, or bovine aspartyl protease (reviewed in references
36 and 47). The 59 GC splice site was also identified at the
second exon/intron border in transiently transfected COS-7
cells. The remainder of the 59 splice sites were CG, and to date
no transcript has been identified with this splice donor. Except
for the 39 TC splice site identified at 7 days p.i., the remainder
of the 39 splice sites have been described for other mRNAs.
The 39 TG splice site identified at 1 day p.i. or in transfected
cells (second 39 splice site) is present in the 39 splice acceptor
site of human or Drosophila melanogaster a subunit of guanine
nucleotide-binding protein (39, 53). The 39 CC splice site ob-
served at 15 days p.i. in transfected COS-7 cells (first 39 splice
site) or infected MDBK cells was described for yeast HAC1
mRNA (67). HAC1 and D. melanogaster a subunit of guanine
nucleotide-binding protein RNAs are alternatively spliced (39,
67). Finally, the 39 AG splice site present at 60 days p.i.
matches HSV-1 LAT (71, 74). In summary, these studies indi-
cated that (i) in TG of latently infected calves, the 59 and 39
splice sites of LRT match HSV-1 LAT; and (ii) most of the
nonconsensus splice sites are utilized by other mRNAs.
Effects of splicing on LR ORFs. The LR gene contains two
open reading frames (ORFs) and two reading frames without
an initiating methionine. One reading frame without an initi-
ating methionine is contained after the three in-frame stop
codons of ORF 2, and the other is in reading frame C. Each
spliced LRT isoform was examined to determine the effect of
splicing on the ORFs. A fusion between ORF 2 and ORF 1 was
generated by splicing at 7 days p.i. in infected MDBK cells or
transfected COS-7 cells (Fig. 7). However, these putative pro-
teins would not be identical because the splice junction signals
are different. At 15 days p.i., the stop codons at the 39 end of
ORF 2 were removed and fused to the reading frame which is
in frame with ORF 2 (Fig. 7). At 1 day or 60 days p.i., the
ORFs were organized in a similar fashion (Fig. 7). Interest-
ingly, at 1 or 60 days p.i., a new ORF which is a fusion between
reading frame C and ORF 1 is generated (Fig. 7). When ORF
2 is fused to ORF 1 (7 days p.i., infected or transfected cells)
or to reading frame B (15 days p.i.), the predicted molecular
masses of these proteins were 35 to 45 kDa. This finding agrees
with previous conclusions that the P2 antibody directed against
the amino terminus of LR ORF 2 recognizes a 40-kDa protein
(35, 65). Although we do not know if these proteins are ex-
FIG. 4. Analysis of LRT expressed in transfected COS-7 or infected MDBK cells. (A) PCR amplification of poly(A)1 LRT from transfected or infected cells. Lane
M, f174 DNA digested with HaeIII; lane 1, RNA prepared from untransfected COS-7 cells; lanes 2 and 3, reactions with (lane 2) and without (lane 3) RT, using
poly(A)1 LRT prepared from COS-7 cells transfected with pcDNA1/LRT; lane 4, RNA prepared from uninfected MDBK cells; lanes 5 and 6, reactions with (lane 5)
and without (lane 6) RT, using poly(A)1 LRT prepared from MDBK cells which were infected for 24 h. The arrow indicates the position of LRT. (B) PCR amplification
of poly(A)2 LRT from transfected or infected cells. Lanes are as in panel A. The top arrow indicates the position of unspliced LRT, and the bottom arrows indicate
the positions of spliced LRT. Sizes are indicated in base pairs.
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pressed in neurons, these studies suggest that alternative splic-
ing of LRT has the potential to generate novel proteins.
DISCUSSION
This study demonstrated that alternative splicing of LRT
occurred in bovine TG compared to nonneural cells. Several
conclusions were drawn from the sequencing data: (i)
poly(A)1 LRT in bovine TG at 7 days p.i. was spliced differ-
ently than at 15 or 60 days p.i., (ii) poly(A)2 LRT detected in
FIG. 6. Summary of spliced poly(A)1 or poly(A)2 LRT. (A) Schematic of
BHV-1 genome, positions of repeats, and positions of map units (mu). Locations
of immediate-early transcripts with respect to LRT are shown (82). Introns of
immediate-early transcripts are presented as dashed lines. Exons are listed as e1
and e2. The e1 of IE2.9 and that of IE4.2 are identical but not protein coding.
The E2.6 transcript does not contain e1, and transcription initiates from a novel
promoter at the 59 terminus of e2. Consequently, the proteins encoded by IE2.9
and E2.6 are identical. (B) Alternatively spliced variants of LRT. The numbers
on the left indicate that RNA was prepared from TG of calves infected for 1, 7,
15, or 60 days. Tr, spliced LRT which was synthesized in COS-7 cells after
transfection with pcDNA1/LRT; In, spliced LRT which was synthesized in
MDBK cells infected with BHV-1 for 24 h. Numbers above the lines indicate the
59 and 39 boundaries of the intron. The schematic in panel A is not drawn to scale
with respect to panel B.
FIG. 5. Determination of DNA sequences of the LRT splice junctions. The
splice junction site was amplified with primers as described in Fig. 1. The
sequence presented on the right is the sense strand. Double asterisks mark the
splice sites of LRT and the sequence which was spliced out (41). The 59 and 39
splice sites are marked with asterisks. The nucleotides that differ from the
published LR gene sequence (41) are underlined. The nucleotides in parentheses
(T at position 1368 in panel A and C and T at positions 1173 and 1368, respec-
tively, in panel B) were detected in this study but not in the previous study (41).
(A) 1 day p.i.; (B) 7 days p.i.; (C) 15 days p.i.
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bovine TG at 1 day p.i. was not the same as LRT detected at
7, 15, or 60 days p.i., (iii) poly(A)1 LRT in transfected or
infected cells which migrated with viral genomic DNA was not
spliced, (iv) poly(A)2 LRT was spliced in productively infected
MDBK cells, and (v) poly(A)2 LRT was apparently spliced at
two positions in transiently transfected COS-7 cells. Although
DNA sequence analysis of splice junction sites suggested that
samples from different times p.i. contained one spliced prod-
uct, the procedures used for amplifying and cloning splice
junction sites would yield the major spliced product. It is also
possible that at other times p.i., different spliced versions of
LRT exist or certain splice variants were not stably cloned. The
finding that nonconsensus splice sites were utilized suggests
that splicing was regulated by a combination of cell-specific
and viral or virus-induced factors.
Several LRT introns are smaller than the 80-nt minimum
intron size which has been proposed for eukaryotes (81). For
example, we detected a 35-nt intron at 60 days p.i. in TG, a
44-nt intron at 1 day p.i. in TG, and a 44-nt intron in transiently
transfected COS-7 cells. The ciliate Paramecium tetraurelia has
introns which are 20 to 33 nt long, and these introns have
consensus eukaryotic splice signals, G(T/A)G (21, 60). Most
fungi or insects, including Drosophila, have introns which range
in size from 31 to 70 nt (51, 61, 73; reviewed in references 31
and 48)). More importantly, the polyomavirus small tumor
antigen transcript contains a 48-nt-long intron which is excised
by a novel mechanism (27), demonstrating that small introns
can be excised in mammalian systems. We hypothesize that
cis-acting sequences within LRT regulate alternative splicing
and mediate excision of short introns. The three in-frame stop
codons at the C terminus of ORF 2 (reference 41 and Fig. 7)
may be important for alternative splicing because it is known
that multiple in-frame stop codons influence cell-specific splic-
ing (2). Although splicing of LRT has unusual features (intron
length and nonconsensus splicing signals, for example), there is
precedence for unusual introns in a variety of organisms.
Splicing is regulated by a complex array of trans-acting fac-
tors, some of which are cell or tissue specific (reviewed in
references 12 and 42). Although 59 splice signals are usually
recognized by small ribonucleoprotein complexes (snRNPs)
which contain the U1 small nuclear RNA (reviewed in refer-
ences 5 and 8), introns containing nonconsensus splice sites are
frequently spliced by less abundant snRNPs (30, 75, reviewed
in reference 69). Serine/arginine (SR) proteins are also impor-
tant for selection of 59 and 39 splice sites (reviewed in refer-
ences 13, 25, 45, 49, and 78). Adenovirus (33, 38), bovine
papillomavirus (84), and HSV-1 (46, 63) alter the distribution
or activity of SR proteins. Neuron-specific or brain-specific
alternative splicing of specific mRNAs has frequently been
observed (1, 6, 7, 44, 72, 77). A neuron-specific splicing regu-
lator (KSRP) is crucial for neuron-specific splicing of c-src (43;
reviewed in reference 29). Finally, alternative splicing of
HSV-1 LAT occurs in neural cells (44) or murine TG (3),
FIG. 7. Organization of ORFs in the LR gene or in alternatively spliced LRT
isoforms. The organization of ORFs in the LR gene was described originally by
Kutish et al. (41). The reading frame in B (open box) that follows LR ORF 2
(stippled box) does not contain a methionine at its amino terminus. The reading
frame in C (black box) does not contain a methionine at its amino terminus.
Asterisks indicate the positions of in-frame stop codons. The hatched box de-
notes ORF 1. Numbers at the top indicate nucleotide positions, and those on the
left indicate that RNA was prepared from TG of calves infected for 1, 7, 15, or
60 days. Tr, LRT synthesized in COS-7 cells transfected with pcDNA1/LRT; In,
LRT synthesized in MDBK cells infected with BHV-1 for 24 h. The sequence of
each LRT variant was analyzed and translated by using the IBI MacVector
sequence analysis software (Kodak).
TABLE 1. Summary of the 59 and 39 splice junctions observed in poly(A)1 and poly(A)2 LR RNAsa
RNAb
Sequence










mRNA consensus (23)A/CAG:GTA/GAGT(15) (215)T/C11NC/TAG:NNN(13)
a The underlined sequences represent the splice signals. The sequences matched to the consensus splice sites are indicated by italicized letters.
b Numbers indicate the LR RNA obtained from TG of infected cattle at the indicated days p.i. Tr and In indicate LR RNA from transfected and infected cells.
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suggesting that neuron-specific splicing has functional signifi-
cance.
Latency has conveniently been divided into three distinct
steps: (i) establishment, (ii) maintenance, and (iii) reactivation.
The finding that LRT is alternatively spliced during establish-
ment (1 to 15 days p.i.) relative to maintenance (60 days p.i.)
suggests that LR gene products have specialized functions
which are necessary for the various stages of latency. During
establishment of latency, it is reasonable to hypothesize that a
viral function represses viral gene expression and enhances
neuronal survival. BHV-1 gene expression in TG, early or
immediate-early, is detected as early as 2 days p.i. and peaks at
7 days p.i. (66). Spliced LRT was detected at 1 day p.i. in TG,
suggesting that it accumulates prior to productive viral gene
expression and thus participates in establishment of latency.
HSV-1 LAT promotes establishment of latency (64, 76) in
mice by repressing productive viral gene expression (16, 26),
adding support to the hypothesis that the LR gene plays a role
in establishment. During maintenance of latency, promoting
neuronal survival would still be important but repression of
viral gene expression does not appear to be as important. A
viral function which promotes viral gene expression or DNA
replication but prevents neuronal death would be advanta-
geous during reactivation from latency. A number of studies
have concluded that HSV-1 LAT mutants do not reactivate
from latency efficiently in vivo (reviewed in references 57 and
58), but the mechanism by which LAT functions in this capac-
ity is unknown. Although it is unlikely that LRT regulates every
aspect of latency, we hypothesize that alternative splicing of
LRT yields novel proteins with specialized functions and that
these protein isoforms are important for certain steps of la-
tency. Cloning and characterizing the various LRT cDNAs
should allow a better understanding of how LR gene products
regulate latency.
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